Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
197
NCT01948362
Sulforadex in Healthy Volunteers SAD
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2012
Completion: Feb 28, 2013
NCT02055716
Sulforadex in Healthy Human Males MAD
Start: Jan 31, 2014
Completion: May 31, 2014
NCT02614742
SFX-01 After Subarachnoid Haemorrhage
Phase: Phase 2
Start: Apr 30, 2016
Completion: Nov 30, 2019
NCT02970682
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer
Start: Oct 31, 2016
Completion: Mar 31, 2019